Brickell Biotech Inc
BBI
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.08M
Close$
$2.69
14.3% upside
Current Fair Value
14.3% upsideUndervalued by 14.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.08 Million |
|---|---|
| Enterprise Value | $-7,399,027.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-22.16 |
| Beta | 0.08 |
| Outstanding Shares | 2,655,251 |
Return
| Return on Equity | -191.07% |
|---|---|
| Return on Assets | -161.44% |
| Return on Invested Capital | -195.24% |
Valuation & Multiples
| P/E Ratio | -0.97 |
|---|---|
| PEG | 1.08 |
| Price to Sales | 2.35 |
| Price to Book Ratio | 0.47 |
| Enterprise Value to Revenue | -1.59 |
| Enterprise Value to EBIT | 0.24 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Brickell Biotech Inc
CEO: Robert Brown